Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy

Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy

US Patent 11958898 · Granted Apr 16, 2024

Estimated economic value: $422,066,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tau single domain antibodies2025
Antibodies binding to phospho-tau comprising phosphorylated Ser396 and Ser404 an2025
Alpha-synuclein single domain antibodies2024
Immunological targeting of pathological tau proteins2023
Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy2022
Antibody-based molecules specific for the truncated ASP421 epitope of Tau and th2021
Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy2020
Antibody-based molecules selective for the {P}Ser404 epitope of Tau and their us2019
Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy2018
Immunotherapy for clearing pathological tau conformers2017
Mucosal immunization to prevent prion infection2017
Method for treating amyloid disease2016